ANS Control of BP Flashcards

1
Q

What is systolic BP

A

pressure inside the arteries when the heart pumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is diastolic BP

A

pressure when the heart relaxes between beats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Normal BP

S: less than ___
AND
D: less than ___

A

120, 80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Elevated BP

S: ___ - ___
AND
D: less than ___

A

120-129
80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

High BP Stage 1

S: ___ - ___
OR
D: ___ - ___

A

130-139
80-89

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

High BP Stage 2

S: ___ or higher
OR
D: ___ or higher

A

140
90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypertensive Crisis

S: higher than ___
and/or
D: higher than ___

A

180
120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HTN

S: > ___ mmHg
D: > ___ mmHg
Resting Pulse Pressure (SBP-DBP) > ___ mmHg
- a pulse pressure > ___ mmHg is unhealthy
- a pulse pressure > ___ is a risk factor for heart disease, especially for old people
- often asymptomatic (may experience ___ or ___ )

A
  • 130
  • 80
  • 65
  • 40
  • 60
  • dizziness, headaches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

relationship between blood pressure and age

T or F: by age 60, the average systolic blood pressure of women exceeds that of men

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

as you get older
- ___ decreases
- ___ inreases

A
  • cardiac output
  • peripheral resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Classifications of HTN

Primary
- ___ - ___ % of all cases, no identifiable cause

Secondary
- has a cause

A

85-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of Secondary HTN

  • ___ disease, ___ artery constriction
  • tumor
  • ___ disease
  • coarctation of the ___
  • pregnancy
  • medication adverse effects
A

kidney, renal
endocrine
aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of Secondary HTN

acronym
ABCDE

A
  • aldosteronism
  • bad kidneys
  • Cushing’s/Coarctation
  • drugs
  • endocrine disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PCOL Strategies for reducing Risk of HTN

BP = ___ x ___
- reduce ___
- reduce vascular ___ (vaso dilation, decrease blood volume)

A
  • cardiac output (CO), peripheral vascular resistance (TPR)
  • CO
  • resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the following will have the greatest impact on the management of HTN
A) addition of 2 glasses of wine with dinner
B) addition of whole milk to diet
C) reduction in red meat
D) replacement of table salt with kosher salt
E) weight reduction

A

E) weight reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T or F: HTN does not self resolve and must be treated for life

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

races most affected by HTN (highest % to lowest)

A
  • black
  • white
  • asian
  • hispanic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CO = ___ x ___

A
  • stroke volume (SV)
  • HR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

SV is determined by:
- cardia ___
- venous return to the heart ( ___ )
- ___ to the left ventricle must overcome to eject blood into the aorta ( ___ )

A
  • contractility
  • preload
  • resistance
  • afterload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Parasympathetic = ___
- endogenous neurotransmitter: ___
- exogenous: ___ and ___

Sympathetic = ___
- endogenous neurotransmitters: ___ and __

A

cholinergic
- ACh
- muscarine, nicotine

adrenergic
- Norepinephrine, epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Adrenergic receptors

a1 = ___ coupled
B = ___ coupled
a2 = ___ coupled

alpha control ____
beta control ___ stimulation

A

Gq
Gs
Gi
- vasoconstriction
- cardiac

a1 is the most involved in vasocontriction, not really a2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

epinephrine binds stronger to ___ than ___

norepinephrine has strong ___ , doesnt really affect heart

A

beta, alpha
vasocontriction

a1 is the most involved in vasocontriction, not really a2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

T or F: the vasculature is controlled only by the PSNS

A

FALSE FALSE FALSE
- SNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

vascular smooth muscle

which two receptors are highly populated in vascular smooth muscle

A

a1 and B2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Adrenergic receptor involvement in blood pressure regulation

Baroreceptor Reflex
decrease in blood pressure
- activates ___ fibers that feed back and innervate the heart ( ___ receptor) - increases HR - reflex ___
- innervate blood vessels ( ___ receptors) resulting in ___
- inhibits vagus ( ___ )
- net result: ___ BP

A
  • SNS, B1, tachycardia
  • a1, vasoconstriction
  • PSNS
  • increased
26
Q

Adrenergic receptor involvement in blood pressure regulation

Increase in blood pressure
- inhibits ___ fibers
- activates vagus ( ___ )
- decrease ___ (reflex ___ )
- no direct effect on ___
- net result: decrease ____

A
  • SNS
  • PSNS
  • HR, bradycardia
  • blood vessels
  • blood presure
27
Q

Adrenergic receptor involvement in blood pressure regulation

NE: raises ___ and lowers ___ (a1, B1)

E: raises ___ and lowers ___ (a1, B1, and B2)

Isoproterenol: raises ___ and lowers ___ (B1, B2)

E more elective for B

NE more selective for a

A
  • peripheral resistance, HR
  • HR, peripheral resistance
  • HR, peripheral resisitance

B2 = vasodilation
B1 = heart stimulation

B1 = heart stimulatio
B2 - vasodialtion

a1 = vasoconstriction

28
Q

Adrenergic receptor involvement in blood pressure regulation

phenylephrine: acting at a receptors
result: ___ in systolic BP, ___ in HR
- a1 effect ___
- activation of baroreceptor reflex which can ___ HR

A
  • increase, decrease
  • vasoconstriction
  • decrease
29
Q

Adrenergic receptor involvement in blood pressure regulation

epinephrine: acting at B and a receptors
result: ___ in systolic pressure, pulse pressure, and HR
- a1 effect: ___
- B2 effect: ___
- B1 effect: positive inotropic and chronotropic effects
- activation of baroreceptor reflex which mitigates the direct effects

A

increase
- vasoconstriction
- vasodilation

30
Q

Adrenergic receptor involvement in blood pressure regulation

isoproterenol: acting at B receptors
result: ___ in diastolic pressure, ___ pulse pressure and HR
- B2 effect: ___
- B1 effect: positive inotropic and chronotropic effects
- activation of barorecptor reflex which could enhance the direct effects

A

decrease, increase
- vasodilation

31
Q

Targets for anti-hypertensives

heart = reduce ___
- both ___ and ___

resistance of ___ and ___

Kidney
- reduce ___ and ___

A
  • cardiac output
  • SNS, PSNS
  • fluids, blood volume
32
Q

Meds indicated for heart failure

A
  • diuretics
  • B blockers
  • ACE inhibitors
  • angiotensisn II receptor blockers
  • aldosterone antagonists
33
Q

Meds indicated for post MI

A
  • B blockers
  • ACE inhibitors
  • angiotension II receptor blockers
  • aldosterone antagonists
34
Q

Meds indicated for diabetes

A
  • ACE inhibitors
  • angiotensin II receptor blockers
  • calcium channel blockers
35
Q

Meds indicated for CKD

A
  • ACE inhibitors
  • angiotensin II receptor blockers
36
Q

which receptor is most present in cardiac muscle?

A

B1

37
Q

a1 antagonists (-osins)

  • ___ produce peripheral ___ without reflex ___ or increased CO
  • acyl moiety determines ___ activity
  • indications: ___ , ___ disease, and ___
  • side effects: first dose phenomenon, postural hypotension and syncope

Examples (3 - in order of increasing t1/2)
- undergo extensive metabolism, excreted in the bile

A
  • quinazolines, vasodilation, tachycardia
  • PK
  • HTN, Reynaud’s, BPH
  • prazosin (3hrs), terazosin (12 hrs), doxazosin (20 hrs)
38
Q

T or F: non-selective a blockers cause reflex tachycardia

A

True
selective (a1 -osins) do not cause tachycardia

39
Q

a2 agonists

reduce BP by reducing ___ output from the brain
Inhibition of ___ release
- decreased ___ tone in CNS
- decreased __
- decreased ___
- decreased ___ release
- decreased ___

A

sympathetic
NE
- sympathetic
- HR
- contractility
- renin
- vasoconstriction

40
Q

Direct acting a2 receptor agonist - clonidine (Catapres)

  • (phenylimino) imidazolidine
  • ____ a2 receptor agonist
  • the basicity of the guanidine group is 13.6 but it is decreased to 8 due to being attached to the ___ ring
  • activation of a2 receptors in the CNS decreases ___ activity; good ___
  • indication: HTN, opiate withdrawal, ADHD
  • Side effects: hypotension, sedation, dry mouth
  • must be ___
A
  • selective
  • dichlorophenyl
  • SNS, lipophilicity
  • tapered
41
Q

Direct acting a2 receptor agonist - Guanabenz and Guanfacine

  • ___ ring imidazolines
  • __ atom bridge to the guanidine group decreases the pKa so the drug is mostly ___ at physiological pH
  • t1/2 guanabenz < guanfacine = clonidine
  • uses: HTN. ADHD (guanfacine)
A
  • open
  • 2
  • non-ionized
42
Q

Direct acting a2 receptor agonist - methyldopa (Aldomet)

  • a ___ metabolized to active a2 receptor agonist, ___
  • ___ - water soluble, ester hydrochloride salt is used for ___ solutions
  • PO = ___ , inj = ___
  • uses: HTN, especially in ___
  • combine with ___ due to sodium/water retention
A
  • prodrug, (1R, 2S) - a - methylnorepinephrine
  • methyldopate, parenteral
  • methyldopa, methyldopate
  • pregnancy
  • diuretic
43
Q

Beta blockers

Hypertension
- decrease ___ output
- inhibition of ___ secretion

A
  • cardiac
  • renin
44
Q

B-Blockers - structure

aryloxypropanolamines

A
45
Q

B-Blocker - propranolol (Inderal)

  • non-selective
  • lipophilic
  • extensive ___ metabolism
  • decreased cardiac __ and ___
  • reduced ___ release
  • increase ___, decrease ___
  • inhibit ___ and compensatory ___ and glucose release in response to ___
  • increase ___ airway resistance
A
  • hepatic
  • output, HR
  • renin
  • VLDL, HDL
  • lipolysis, gluconeogenesis, hypoglycemia
  • bronchial
46
Q

B-Blockers - Nadolol (Corgard)

  • non-selective
  • less lipophillic than ___
  • ___ t1/2
  • mostly excreted unchanged in ___
  • administered PO
  • use: hypertension, angina, migraine
A
  • propanolol
  • long
  • urine
47
Q

B-Blockers - Timolol (Timoptic, Blocadren)

  • non-selective
  • thiadiazole nucleus with morpholine ring
  • administered PO, ophthalmic
  • uses: glaucoma, HTN, angina, migraine
A
48
Q

B-Blockers - pindolol (Visken)

  • non-selective
  • intrinsic sympathomimetic activity
  • ___ agonist
  • less likely to cause ___ and lipid adnormalities
  • good for patients who have severe ___ or little cardiac reserve
A
  • partial
  • bradycardia
  • bradycardia
49
Q

B-blockers - carteolol (Cartrol, Ocupress)

  • non-selective
  • intrinsitc sypathomimetic activity
  • partial ___
  • less likely to cause ___ and lipid abnormalities
  • administered: PO, ophthalmic
  • uses: hypertension, glaucoma
A
  • agonist
  • bradycardia
50
Q

B-blockers - metoprolol (Lopressor, Toprol) and bisoprolol (Zebeta)

  • ___ selective
  • ___ substituted phenyl derivatives
  • “cardioselective”
  • less ___
  • moderate lipophilicity
  • significant first pass metabolism
  • uses: HTN, angina, anti-arrhythmic, CHF
  • rebound HTN is discontinued abruptly - ___ dose
A
  • B1
  • para
  • bronchoconstriction
  • taper
51
Q

B-blockers - atenolol (Tenormin)

  • selective ___
  • “cardioselective”
  • less ___
  • low lipophilicity “water soluble ___ “
  • PO and inj
  • uses: HTN, angina
A
  • B1
  • bronchoconstriction
  • metoprolol
52
Q

B-blocker - esmolol (Brevibloc)

  • ___ selective
  • very short acting
  • half life: 9 min
  • rapid hydrolysis by ___ found in red blood cells
  • administered: ___ , incompatible with sodium bicarb
  • uses: supravenricular tachycardia, atrial fibrillation/flutter, perioperative hypertension
A

B1
esterases
parenteral

53
Q

B-blocker - nebivolol (Bystolic)

  • 3rd generation
  • ___ selective
  • vasodilation due to ___ production
A

B1
nitric oxide

54
Q

B-blockers

SE
- ___ cardia
- ___ block
- sedation
- mask symptoms of ___ , withdrawal syndrome

Containdications:
- ___ and ___
- congestive HF type ___

A
  • bradycardia
  • AV
  • hypoglycemia
  • asthma, COPD
  • IV
55
Q

effect of chronic B-receptor block
- more ___ will grow

A

B-receptors

56
Q

Mixed adrenergic receptor antagonists - labetalol (Normodyne, Trandate)

  • ___ B receptor antagonist
  • ___ receptor antagonists
  • B blocking activity prevent reflex ___ normally associated with ___ receptor antagonists
  • administered: oral and parenteral
  • uses: HTN, hypertensive crisis
  • 1R, 1’R - isomer possesses ___ blocking activity
  • 1S, 1’R isomer possesses greatest ___ receptor blocking activity
A
  • non selective
  • a1
  • tachycardia, a1
  • B
  • a1
57
Q

Mixed adrenergic receptor antagonists - carvedilol (Coreg)

  • ___ B receptor antagonist
  • ___ receptor antagonist
  • both enantiomers antagonize ___ receptors
  • only S enantiomer posses ___ blocking activity
  • B blocking activity prevent reflex ___ normally associated with ___ receptor antagonists
  • PO
  • uses: HTN, CHF
A
  • non-selective
  • a1
  • a1
  • B
  • a1
58
Q

Beta blocker withdrawal
___ the dose when DC

A

taper

59
Q

D1 receptor agonist - Fenoldopam

used in __ HTN
prolems: should not be used in patients with ___ due to increases in IOP
notes: maintains or ___ renal perfusion while lowering ___ ‘ paticularly useful in patients with ___ impairment

A

severe
glaucoma
increases, BP
renal

60
Q

Catecholamine Synthetic Path

inhibiting with Metyrosine

action: inhibits ___ hydroxylase

Clinical Uses: perioperative management of ___

problem: depletes ___ everywhere

A
  • tyrosine
  • pheochromocytoma
  • catecholamines

pheochromocytoma - tumor in adrenal gland that makes excess E and NE

61
Q

VMAT Inhibitor Reserpine

Action:
- nonselective, ___ inhbitor of vesicular monoamine transporter (VMAT)
- depletes stored ___

Clinical Use
- HTN but rarely used due to AE

Problems:
- expected peripheral adverse effects (orthostatic, hypotension, increased GI activity)
- CNS effects such as sedation severe depression/suicide

A
  • irreversibel
  • NE
62
Q

Catecholamine depleters - Reserpin (Serpasil)

  • indole alkaloid obtained from root of Rauwolfia serpentina
  • block vesicular monoamine transporters
  • depletes vesicular pool of NE
  • slow onset of action
  • sustained effects (weeks)
A